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D.G. Bountouroglou, M. Azzam, S.K. Kakkos, M. Pathmarajah, P. Young
and G. Geroulakos*Josef Pflug Vascular Laboratory and the Vascular Unit, Ealing Hospital, Department of Vascular Surgery,
Imperial College, London, UKAim. This study is a prospective randomised controlled trial comparing sapheno-femoral ligation, great saphenous stripping
and multiple avulsions with sapheno-femoral ligation and ultrasound guided foam sclerotherapy to the saphenous vein.
Primary end points were patient recovery period and quality of life and secondary end points frequency of complications on
the two arms of the trial and the cost of the treatment.
Material and method. Sixty patients with primary varicose veins due to GSV incompetence and suitable for day case
surgery were randomly allocated to undergo ultrasound-guided sclerotherapy with sapheno-femoral ligation under local
anaesthesia (nZ30) or sapheno-femoral ligation, stripping and multiple avulsions under general anaesthesia (nZ30).
The study protocol included history, physical examination, assignment of CEAP class and assessment venous clinical
severity score (VCSS), completion of the aberdeen vein questionnaire (AVQ) and colour duplex ultrasound.
Results. All treatments were completed as intended. Median time to return to normal activities was significantly reduced in
the foam sclerotherapy group (2 days) compared to the surgical group (8 days) (p!0.001, Mann–Whitney).
AVQ score was also significantly reduced at 3 months by 46% in the sclerotherapy group, and by 40% in the conventional
surgery group (p!0.001, Wilcoxon).
The time taken to complete treatment was shorter in the foam sclerotherapy plus SFJ ligation group: 45 vs. 85 min
(p!0.001, Mann–Whitney).
The overall cost of the procedure in the sclerotherapy group (£672.97) was significantly less compared to conventional
surgery (£1120.64).
At 3 weeks, there was no statistical difference in the complication rate between the two groups. At 3 months, median CEAP
class dropped from four pre-operatively to one following treatment in both groups and the median VCSS score dropped from
five to one in group one and from seven to three in group two (p!0.001, Wilcoxon test). In group one four patients (13%)
had a recanalised vein which needed further sessions of foam sclerotherapy, resulting in a short-term closure rate of 87%.
Conclusion. Ultrasound guided sclerotherapy combined with sapheno-femoral ligation was less expensive, involved a
shorter treatment time and resulted in more rapid recovery compared to sapheno-femoral ligation, saphenous stripping and
phlebectomies.Keywords: Randomised trial; Ultrasound-guided foam sclerotherapy varicose veins; Quality of life; Varicose vein surgery.Introduction
Ligation of the saphenofemoral junction (SFJ), strip-
ping of the great saphenous vein (GSV) and multiple
phlebectomies is considered the standard treatment
for varicose veins. This achieves rapid relief ofing author. Dr George Geroulakos, FRCS, PhD,
enior Lecturer, Department of Vascular Surgery, Faculty
Imperial College, Charing Cross Hospital, Fulham
London W6 8RF, UK.
: g.geroulakos@imperial.ac.uk
0093 + 08 $35.00/0 q 2005 Elsevier Ltd. All rights resersymptoms and has an acceptable long-term recurrence
rate.1,2 Any alternative technique must have the same
or better outcome with fewer complications or
reduced cost. Stripping of the GSV is not used at
present in some centres on the basis that selective
ligation of incompetent veins is as effective as
stripping and results in less morbidity by decreasing
the incidence of thigh haematomas and post-operative
pain. However, it has been reported that the residual
incompetent GSV results in a higher recurrence rate for
varices.3 Others have proposed ligation of major sitesEur J Vasc Endovasc Surg 31, 93–100 (2006)
doi:10.1016/j.ejvs.2005.08.024, available online at http://www.sciencedirect.com onved.
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D. G. Bountouroglou et al.94of venous incompetence such as the SFJ followed by
sclerotherapy of the GSV.3 Foam sclerotherapy under
ultrasound control is a relatively new technique that
appears to be safer and more effective than liquid
sclerotherapy.4–7
The present study was designed as a prospective
randomised comparison of conventional GSV strip-
ping and SFJ ligation under general anaesthesia with
ultrasound guided foam sclerotherapy and SFJ lig-
ation under local anaesthetic. The primary outcome
measures were time for post-operative recovery and
return to work and quality of life (QOL) outcomes and
the secondary outcome measures frequency of com-
plications and cost of treatment.Analysed n=29.1 patient
did not attend the F/U
Analysed  n=23. 5 patients
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F
F/
U
 a
t 3
 m
on
th
s
Fig. 1. CONSORT diagram showing flow of patents through
the study.Materials and Methods
The study protocol was approved by the Hospital
Ethics Committee. Patients with symptomatic primary
varicose veins (VV) due to GSV incompetence
attending the vascular outpatient clinic of Ealing
Hospital were invited to participate in this study.
Patients who gave informed written consent were
included. Sixty patients, 32 female and 28 male with a
median age of 43 years (range 20–72 years), meeting
the inclusion and exclusion criteria listed in Table 1
were enrolled and randomised between July 2003 until
February 2004. The randomisation was done with
sealed envelopes prepared by STD Pharmaceuticals
Ltd the study sponsors. After consent had been
obtained, the envelope assigned to the patient was
opened allocating him/her to one of the two groups:
SFJ ligation, GSV stripping and phlebectomies (sur-
gery group) or SFJ ligation under local anaesthetic and
foam sclerotherapy to the GSV (foam sclerotherapy
group). Thirty patients were allocated to the foam
sclerotherapy group and 30 to the surgery group. OnlyTable 1. Inclusion and exclusion criteria
Inclusion criteria
Patients with primary symptomatic varicosities involving the LSV
system
No previous treatment for varicose veins
Suitability for day-case surgery
Exclusion criteria
Patients with primary varicosities involving both the LSV and SSV
Patients with previous surgery for varicose veins
Patients previously treated with sclerotherapy for varicosities
Previous DVT
Risk factors for DVT (apart from varicose veins)
Coagulopathy
Peripheral vascular disease
Known allergy to local anaesthetic or sclerosing agents
Previous iatrogenic allergic reaction
Malignancy
Pregnancy
Eur J Vasc Endovasc Surg Vol 31, 1 2006one leg per patient was included in the study in
patients with bilateral varicose veins the most severely
affected limb was randomised for the purposes of this
investigation. The flow of patients in this study is
shown in Fig. 1.Investigation protocol
The investigation protocol entailed: history; physical
examination and allocation to the appropriate CEAP8,10
clinical stage and venous clinical severity score (VCSS)
classification.11,23 Lower limb venous duplex ultra-
sound examination was undertaken and patients
completed the Aberdeen Vein Questionnaire (AVVQ).
This was employed to assess the impact of treatment on
the quality of life.12
On clinical examination all patients had normal
pulses in the lower limb and there was no clinical
evidence of peripheral arterial disease. The examin-
ation also included screening the superficial venous
system of the lower limb with continuous-wave
Doppler ultrasound. Limbs were classified according
to the CEAP system,8 and quantification of clinical
severity was performed using the VCSS introduced by
Rutherford et al.12
Lower limb venous duplex scanning was per-
formed by the same operator (MA), using an Acuson
(Aspen Advanced, Acuson Corporation, USA) fitted
with a 4–8 MHz linear array transducer. The examin-
ation was performed with the patient standing. Reflux
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a manual compression-release manoeuvre.Operative procedure
All patients treated in this study were managed in our
day surgery unit with the aim of discharging them
from hospital on the day of treatment.
In the surgery group, the operation was performed
under general anaesthesia. Following SFJ ligation,
GSV stripping was performed using an inversion
technique from proximal to distal using a plastic
stripper. The GSV was stripped from the SFJ to just
below the knee. Varicosities were treated by phle-
bectomy using Mu¨ller’s hooks, through multiple
small incisions. After wound closure compression
bandages were applied, which were changed for a
class 1 (Germany) elastic stocking (MEDIVEN
PLUSe, Medi, Bayreuth, weihermuller, Beyreuyh,
Germany) (18–21 mmHg) prior to patient discharge
from the day ward, and maintained for 3 weeks. All
patients were instructed to walk for 1.5–2 mile on a
daily basis.
The duration of the treatment was recorded in the
two groups. The operating time in the surgery group
incorporated the anaesthetic preparation of the
patient. The operating time in the foam sclerotherapy
group incorporated the sclerotherapy session.
In the foam sclerotherapy group, the procedure was
performed under local anaesthesia, which consisted of
10 ml of bupivacaine 0.5%, prior to the groin incision
and lignocaine 1% with adrenaline (1:100.000) as
needed during the procedure. SFJ ligation was
performed in the same way as in the surgery group.
Post-operatively, the patient was transferred to the
ultrasound suite where foam injection sclerotherapy
with 6 ml of sclerosing foam under ultrasound control
was performed. The sclerosing foam was prepared
using the Tessari method,13 with two disposable 5 ml
syringes and a three-way stop-cock. One part of 3%
STD (Fibroveine, STD Pharmaceutical Products Ltd,
Hereford, UK) and four parts of air were used to
produce the sclerosing foam. A suitable varicose vein,
connecting with the GSV trunk, preferably below the
knee, was selected, marked with the aid of ultrasound
and with the patient in supine position, was sub-
sequently canulated with a 21-gauge butterfly. The
limb was then elevated to 45 8 and the sclerosing foam
injected. Directional control of sclerosant flow was
accomplished by application of pressure with the
ultrasound transducer along the course of the treated
vein(s). Any perforating veins were protected by
applying digital pressure to prevent foam enteringthe deep venous system. The aim was first to treat and
obliterate the segment of the GSV that otherwise
would have been stripped.
On completion, the deep venous system was
scanned to identify any foam leakage. Short stretch
bandages (CEB IDEAL BP elastic, Karl Otto Braun,
Germany, 7.5 and 10 cm wide) with latex foam rubber
pads (STD Pharmaceutical Products Ltd, Hereford,
UK) were applied in the treated area and a class I
(Germany, 18–21 mmHg) thigh-high stocking with a
waist attachment (MEDIVEN PLUSe, Medi, Bayr-
euth, Germany) was worn. Patients were instructed to
wear the stocking continuously for 2 weeks. During
the third week patients were allowed to wear the
stocking in the daytime only. Patients were advised to
walk for 1.5–2 mile daily, starting on the day of the
operation. The authors admit that there is no scientific
evidence to support this regime but have found it
useful advice to offer in order to facilitate recovery of
their patients to normal activity following this type of
surgery.Follow-up
All patients were reviewed and examined 3 weeks and
3 months post-operatively. The follow-up evaluation
at 3 weeks included history, physical examination and
colour duplex venous ultrasound. History and physi-
cal examination were aimed at detecting any compli-
cation. The colour duplex examination stratified the
GSV system as fully obliterated (1), partially obliter-
ated with (2a) or without (2b) reflux, or not obliterated
(3). In addition, the presence of DVT was sought. The
common femoral vein, the femoral vein, the popliteal
vein, the posterior tibial veins, the peroneal veins, the
soleal veins and the medial and lateral gastrocnemius
vein were investigated by colour duplex ultrasono-
graphy using a standardised technique.9
All patients with residual varicose veins in both
groups received additional foam (foam sclerotherapy
group) or liquid (surgery group) sclerotherapy treat-
ment as outpatients. The follow-up evaluation at 3
months included classification using the CEAP and
VCSS systems and the completion of the AVVQ.Statistical analysis
Non-parametric tests, Wilcoxon signed ranks test and
Mann–Whitney test, were used for statistical analysis
of paired data (i.e score changes overtime) and
unpaired data (i.e. differences between groups),
respectively. Calculation was performed with the
statistical package SPSS for Windows (version 11.5),Eur J Vasc Endovasc Surg Vol 31, 1 2006
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Fig. 2. Length of time until return to normal physical activity
(p!0.001, Mann–Whitney test). The box and whisker plot
shows the median, inter-quartile range and maximum and
minimum values.
D. G. Bountouroglou et al.96Chicago, IL, USA; Figs. 2 and 3 were prepared using
the statistical package STATISTICA (version 7). The
descriptors used in these figures are the median,
interquartile range and maximum and minimum
values. Before the authors started this study there
was no detailed information on the main outcome
measures that we wished to investigate. The patients
reported here represent our initial experience of this
technique. We, therefore, had no reliable data on
which to base power calculations in order to establish
an appropriate sample size. The number of patients
included was determined by the maximum that wasGroup
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Fig. 3. Length of time of the operative procedure (p!0.001,
Mann-Whitney test). The box and whisker plot shows the
median, inter-quartile range and maximum and minimum
values.
Eur J Vasc Endovasc Surg Vol 31, 1 2006feasible taking into account the resources available to
the authors.Results
All treatments were completed as intended and no
procedure was abandoned due to technical difficulty.
Two patients in the conventional surgery group have
not yet had their operation and were not included in
the final analysis. One of them changed his mind and
did not want to have the operation and the other has
moved to a different area. Two patients in the foam
sclerotherapy group received the same treatment to
the other leg at their request, but these added
procedures were not part of the trial and were not
included in the final data analysis. The two patient
groups had comparable demographics, CEAP classi-
fication, and clinical severity of venous disease (VCSS)
as shown in Table 2.
The time until return to work or back to normal
activity ranged from 0 to 6 days (median 2) in the foam
sclerotherapy group, and from 5 to 20 days (median 8)
in the surgery group (Fig. 2). The difference was
statistically significant (p!0.001, Mann–Whitney).
Quality of life analysis with the AVVQ showed that
median scoring decreased from 15.4 to 9.3 (46%) in the
foam sclerotherapy group and from 26.1 to 14.1 (40%)
in the surgical group after 3 months (p!0.001,
Wilcoxon).
Treatment time for the two techniques is shown in
Fig. 3. The length of the procedure ranged from 45–
60 min (median 45) in the foam sclerotherapy group,
and from 70–95 min (median 85) in the surgery group
(p!0.001, Mann–Whitney). The procedural cost of the
two techniques is analysed in Table 3.
The total cost of the procedure in group 1 was £672.97
(GBP) as compared to £1120.64 (GBP) in group 2.Table 2. Demographics, CEAP and VCSS before treatment
(significance testing: Mann–Whitney U-test)
Foam scler-
otherapy group
Surgical group p value
Age 21–72
(median 43)
20–76
(median 43)
NS
Female gender 14 (47%) 18 (60%) NS
CEAP clinical class
2 11 (37%) 8 (27%) NS
3 8 (27%) 14 (47%) NS
4 7 (23%) 6 (20%) NS
5 3 (10%) 1 (3%) NS
6 1 (3%) 1 (3%) NS
VCSS 2–13
(median 7)
2–16
(median 5)
NS
Table 3. Early post-operative complications
Complications Foam sclerother-
apy group
Surgery group
Groin infection 2 2
Skin pigmentation 2 1 (skin ulcer)
Sup. thrombophlebitis 3 –
Allergy – –
DVT – –
Saph. nerve injury – 2
Other – 2 (haematoma,
retention)
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Complications arising from the procedure were
infrequent in both groups (Table 4). Two groin
infections occurred in each group and were treated
successfully with antibiotics. There were two cases of
skin pigmentation and one case of superficial
thrombophlebitis in the sclerotherapy group. One
groin haematoma, which needed surgical evacuation,
and an immediate post-operative urinary retention,
occurred in the surgery group. The latter patient
was kept overnight in hospital. There were no
significant complications, such as deep vein thrombo-
sis (DVT), pulmonary embolism, peripheral nerve
injury, skin necroses, or allergic reaction to the
sclerosing drug.
Four patients (13.3%) in the foam group needed a
second session of sclerotherapy for full obliteration of
the GSV system. This resulted in a mean of 1.13Table 4. Expenditure of the procedure in the two groups
Surgery Comment
Surgeon @ £1.17 per min
Assistant @ £0.49 per min
Anaesthetist @ £1.17 per min
Nursing @ £0.68 per min
Anaesthetic Standard v local (ignoring gas/
vapor and monitoring cost)
Anaes assistant @ £0.25 per min
Consumables Stripper v STS
Antiembolism stockings
Sterile supplies
Subtotal A
POST OP
Theatre recovery @ £100 per h
Ward time @ £100 per h
Lost time before return
Normal activities
Ultrasound 15 min scan. This cost can be
eliminated by using handheld
devices in theatre, adding
10 min to the theatre time, or
£23.40
Medical attendance
Capital and overhead
Subtotal B
Grand totalsclerotherapy sessions per patient to completely
occlude the GSV.
In the stripping group two patients (7%) needed a
further sclerotherapy session for full obliteration of
their residual veins.
Fifty-one patients (28 patients in group one and 23
patients in group 2) have so far been followed up at 3
months.
Five patients in the foam group (17%) had
developed resolving skin pigmentation and three
(10%) had had an episode of self-limited superficial
thrombophlebitis. In the conventional surgery group
two patients (9%) complained of symptoms
suggesting saphenous nerve injury, and one patient
(4%) developed a skin ulcer following liquid injection
sclerotherapy for her residual varicose veins.
The median CEAP class dropped from four pre-
operatively to one following treatment in both
groups and the median VCSS score dropped from
five to one in group one and from seven to three in
group two (p!0.001, Wilcoxon test, Table 5). In both
groups the changes of the VCSS score and CEAP
class pre- and post-operatively were comparable.
In the foam sclerotherapy four patients (13%) had
recanalised a vein (2b or 3) needing further sessions of
foam sclerotherapy, resulting in a short-term closure rate
of 87%. In group two there were two cases of incomplete
stripping (accessory LSV) resulting in a short-term
obliteration of 93%. Table 6 summarises the post-
operativeultrasoundscanassessmentoftheGSVsystem.Conventional Foam injection sclerotherapy
£93.60 £40.95
£39.20 £17.15
£93.60 £0.00
£54.40 £23.80
£8.36 £2.84
£20.00 £0.00
£8.55 £4.69
£7.00 £17.50
£80.56 £80.56
£405.27 £187.49
£83.33 £40.00
£491.67 £258.33
7 days 2 days
£0.00 £50.00
£7.95
£ 140.37 £71.70
£715.37 £485.48
£1,120.64 £672.97
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Table 5. Effect of procedure on CEAP and VCSS stratification
Foam sclerotherapy Surgery
Pre Post Pre Post
CEAP
Median (range) 4 (2–6) 1 (0–5) 4 (2–6) 1 (0–5)
VCSS
Median (range) 5 (2–13) 1 (0–5) 7 (2–16) 3 (0–4)
(p!0.001, Wilcoxon)
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Rutgers and Kitslaar,3 and Jones et al.14 have shown
that SFJ ligation with stripping of the great saphenous
vein is associated with lower recurrence rate of reflux
and VVs than SFJ ligation alone. SFJ ligation was
associated with increased morbidity consisting of
post-operative pain and bruising. In the present
study the inversion technique for stripping of the
GSV was used.
In a randomised trial,15 comparing the GSV
stripping to liquid sclerotherapy given without
ultrasound guidance five hundred patients were
followed up for up to 6 years. At 1 year sclerotherapy
was more effective with a very high cure rate (95%) but
this began to fail at 2 years (67%). The cure rate
decreased markedly during the fourth (17%), fifth
(10%) and sixth (5%) years after treatment. At 1 year
surgery showed a lower success rate (60%), but this
did not fall rapidly with time. Cavezzi et al.17 followed
up 177 limbs for a mean time of 138 days and observed
a 33% recurrence rate after ultrasound guided foam
sclerotherapy for varicose veins. Cabrera et al.16
treated five hundred limbs with ultrasound guided
foam sclerotherapy and report an 81% obliteration rate
after 3 years follow-up.
Ultrasound guided foam sclerotherapy appears to
be superior to liquid sclerotherapy4–7 (or Orbach’s
froth). A randomised study of 25 patients treated with
liquid sclerotherapy or saline injections identified
23.2% of recanalisation rate after 3 months in theTable 6. Ultrasound follow-up investigation (LSV system.1, full
obliteration; 2a, partial obliteration without reflux; 2b, partial
obliteration with reflux; 3, no obliteration)
u/s
grade
3 weeks 3 months
Legs % Legs %
Foam scler-
otherapy
group
1 25 83 23 79
2a 1 3.3 2 7
2b 4 13.3 4 14
3 0 0 0 0
Surgery group 1 25 89.3 18 78.3
2a 1 3.6 1 4.3
2b 2 7 4 17.4
3 0 0 0 0
Eur J Vasc Endovasc Surg Vol 31, 1 2006sclerotherapy group.18 Hamel-Desmos et al. compared
early results between foam and liquid sclerotherapy.20
Eighty-eight limbs were randomised and the 3 weeks
follow-up identified 84% GSV obliteration in the foam
group and only 40% in the liquid sclerotherapy group.
The high incidence of recurrence is largely the result
of recanalisation of the GSV following sclerotherapy.
Therefore, in this study we combined high ligation
with sclerotherapy, a treatment that theoretically
would have a lower recurrence rate than sclerotherapy
alone. Our recanalisation rate of the GSV was lower
than the one reported by Cavezzi et al. who used a
similar technique without ligating the SFJ. We
acknowledge that the technique used by Cavezzi
differs from ours. Another advantage of ligating the
SFJ is that the tributaries are also ligated during this
operation. These remain patent following sclerother-
apy and may act as a source of recurrence.2,19
A theoretical long-term disadvantage of the ligation
of the SFJ is that this procedure could induce neo-
vascularisation of the saphenofemoral junction, which
results in varicose vein recurrence. Neo-vascularisa-
tion is a common cause of recurrent varicose veins.
A randomised study reported in a 2 year follow-up a
35% of recurrence after high ligation with (25%) or
without (43%) stripping. 52% of the recurrences was
found to be due to neo-vascularisation.21 In our study,
this problem will need to be quantified and addressed
in the long-term follow-up of our patients.
The authors are aware that retrograde injection of
the saphenous trunk with liquid sclerosants at the time
of surgery has been reported. We opted to use foam
injections and monitor the extent of spread of the foam
during treatment. Since, ultrasonography was not
available to us in the operating theatre we decided to
treat patients in a separate session where we could
direct foam to the saphenous trunk and as many
varices as possible. We found it sufficient to inject a
tributary of the saphenous trunk in this series. We
acknowledge that in many of the published series on
this subject the sclerosant foam has been delivered
directly into the saphenous trunk. We considered that
in our patients where the sapheno-femoral junction
had been ligated surgically the increased complexity
and possible risks of injection of the saphenous trunk
could be avoided. Our results have so far confirmed
that this strategy was effective. Prior ligation of the SFJ
may also increase the safety of this procedure by
limiting the spread of sclerosant foam to the femoral
vein.
This prospective randomised trial provides direct
comparison of the early post-operative course after
conventional treatment of primary varicose veins with
SFJ, stripping and avulsions, and ultrasound-guided
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anaesthetic. The operative time of the two treatments
in this study proved to have a significant reduction if
favour of the foam group. In this study the scler-
otherapy session was carried out in the ultrasound
suite after the operation. The mean time of the
procedure was 15 min. If the sclerotherapy procedure
was done in theatres then the operative time would
have been even less.
We found that patients in the foam sclerotherapy
group returned to work earlier than those in the
surgery group (median 2 vs. 8 days). Recovery was
quicker, early cosmesis was better with fewer incisions
in patients treated with foam.
Quality of life analysis showed that the foam and
high ligation technique achieved reduced discomfort
from varices and cosmetic improvement comparable
to that achieved in the conventional surgery group.
The cost of the procedure was found to be almost
half (£673 vs. £1121) for patients treated with foam
sclerotherapy and high ligation. The cost of the
procedure does not take into account socio-economic
benefits and in particular the much earlier return to
professional activities among those treated with foam
sclerotherapy. This has important implications in the
era of day case surgery, because it could result in more
patients being treated during a day list, thus reducing
the long waiting lists in varicose vein surgery.
Complications were similar in both groups, being
more annoying than serious. The groin infection rate
in each group (6.6%) although higher than the figures
described in textbooks (!5% in clean operations),
were lower than the reports of a prospective study
which showed a surprisingly high overall infection
rate of 13.5% in 126 patients after vein stripping.22
The rate of the GSV system obliteration was equal in
the two study groups, and in accordance with other
studies6,23 stratification of patients in the CEAP class
and VCSS showed a significant decrease in scoring in
both groups.
The ideal treatment for varicose veins should be
relatively non-invasive, repeatable if necessary; rela-
tively safe and free of significant complications;
effective in eliminating points of leakage, thus
decreasing venous hypertension and resulting com-
plications; cost-effective; cosmetically acceptable
(improving appearance while leaving few, if any,
permanent areas of discoloration or scars); obviate
the necessity for extended periods of unemployment
or absence from usual daily activities. Foam scler-
otherapy with SFJ ligation under local anaesthetic, as
assessed in the short term meets all of the above
criteria.We have shown that there are significant early
advantages with the new technique versus the
conventional operation in the management of primary
varicose veins. Long-term studies are needed to
determine the ultimate fate of the residual GSV after
foam sclerotherapy.Acknowledgements
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